Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tazarotene Cream 0.1% vs Tazorac in Acne Vulgaris
NCT02411955Phase 1Completed
- Start
- Jun 2014
- Primary completion
- Jan 2015
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, double-blind trial of tazarotene in acne vulgaris (3 arms). Primary endpoints: Change in inflammatory lesion counts at 12 weeks and Change in non-inflammatory lesion counts at 12 weeks. Started Jun 2014; status: completed.
02
Drugs
tazarotene
03
Conditions
acne vulgaris
Beyond the preview
Go deeper on NCT02411955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02411955.